Avistone Announces the First Approval of Vebreltinib for MET Exon 14 Skipping Non-Small Cell Lung Cancer Opening a New Chapter in MET-targeted Treatment of Lung Cancer
BEIJING--(BUSINESS WIRE)--Avistone Biotechnology Co. Ltd. (“Avistone†or “the Companyâ€), an innovative biotechnology company focused on…